Systematic review of genome-wide association studies of abdominal aortic aneurysm
نویسندگان
چکیده
Background and aimsAbdominal aortic aneurysm (AAA) is an important cause of death worldwide has estimated heritability between 70 77%. Genome-wide association studies (GWAS) are established way to discover genetic risk variants. The aim this study was systematically review the findings quality previous AAA GWAS.MethodsThe Medline, PubMed, Web Science relevant databases were searched identify GWAS. A framework developed grade methodological Data from included extracted assess methods findings.ResultsEight case-control included. Thirty-three 38 total single nucleotide polymorphisms (SNPs) previously reported associated with diagnosis at genome-wide significance (p < 5.0 × 10−8). CDKN2B antisense RNA-1 gene had most significant = 6.94 10−29 p 1.54 10−33 for rs4007642 rs10757274 respectively). Age, sex smoking history not complete cohort in any studies, although five eight adjusted or matched least two confounding variables. All design limitations including lack sample size estimation, inconsistent case control ascertainment limited phenotyping AAAs. growth assessed one GWAS, however, no associations SNPs found.ConclusionsThis systematic identified 33 validated multiple cohorts. adequately examined. Previous GWAS have a number limitations.
منابع مشابه
Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci
RATIONALE Abdominal aortic aneurysm (AAA) is a complex disease with both genetic and environmental risk factors. Together, 6 previously identified risk loci only explain a small proportion of the heritability of AAA. OBJECTIVE To identify additional AAA risk loci using data from all available genome-wide association studies. METHODS AND RESULTS Through a meta-analysis of 6 genome-wide assoc...
متن کاملSystematic review: repair of unruptured abdominal aortic aneurysm.
BACKGROUND Recent recommendations to screen for abdominal aortic aneurysm (AAA) in high-risk populations and the rapidly increasing use of endovascular repair have led to increased interest in evaluating the effectiveness of treatment options for patients with AAA. PURPOSE To compare the effectiveness of treatment options, including active surveillance, open repair, and endovascular repair, f...
متن کاملDrug Therapy for Small Abdominal Aortic Aneurysm
Dear Editor,Abdominal aortic aneurysm is often asymptomatic, less recognized, and causes considerable mortality and morbidity, if missed. The incidence varies from country to country and the occurrence is influenced by modifiable (smoking, coronary heart disease, hypertension, dyslipidemia, and prolonged steroid therapy) and non-modifiable risk factors (increasing age, male gender, and positive...
متن کاملA Systematic Review of Studies Examining Inflammation Associated Cytokines in Human Abdominal Aortic Aneurysm Samples
OBJECTIVES Inflammation is critical in abdominal aortic aneurysm (AAA) but there is no current consensus on which inflammation related cytokines are important. The aim of this review was to systemically assess previous studies investigating the relative expression of inflammation associated cytokines within human AAA samples. METHODS The MEDLINE database was searched for studies which simulta...
متن کاملPersistent chronic peri-aortitis ('inflammatory aneurysm') after abdominal aortic aneurysm repair: systematic review of the literature.
Data on the outcome of aneurysmal chronic peri-aortitis ('inflammatory aneurysm') after open surgical aneurysm repair are few and contradictory. To what extent this inflammatory process is reversed after endovascular aneurysm repair (EVAR) is even more unclear. The objective of this review was to study the outcome of peri-aortic fibrosis (PAF) and ureteral obstruction in patients with aneurysma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Atherosclerosis
سال: 2021
ISSN: ['0021-9150', '1879-1484']
DOI: https://doi.org/10.1016/j.atherosclerosis.2021.05.001